Summary. Diabetic neuropathy results from progressive nerve fibre damage with blunted nerve regeneration and repair and may be complicated by nerve hyperexcitability resulting in pain. The naturally occurring amino acid taurine functions as an osmolyte, inhibitory neurotransmitter, and modulator of pain perception. It is also known to have neurotrophic actions. The compatible osmolyte hypothesis proposes that levels of intracellular organic osmolytes including taurine and myo-inositol, respond co-ordinately in response to changes in intracellular sorbitol or external osmolality to maintain the intracellular milieu. We hypothesize that glucose-induced sorbitol accumulation in diabetes mellitus will result in taurine depletion in peripheral nerve which may potentially impair nerve regeneration and precipitate neuronal hyperexcitability and pain. This study explored the relationships of taurine, myo-inositol and sorbitol in the rat nerve and their effects on nerve conduction velocity. Osmolyte levels and nerve conduction velocity were determined in sciatic nerve from non-diabetic and streptozotocin-induced diabetic rats, with or without dietary taurine or myo-inositol supplementation. Taurine levels decreased by 31% (p < 0.01) and myo-inositol decreased by 37% (p <0.05) in diabetic nerve as sorbitol accumulated. Taurine supplementation of diabetic animals did not affect nerve conduction velocity but further reduced nerve myo-inositol levels. Prevention of sorbitol accumulation with the aldose reductase inhibitor sorbinil increased nerve taurine levels by 22% (p < 0.05) when compared with untreated diabetic animals. Thus, we have demonstrated an interdependence of organic osmolytes within the nerve. Abnormal accumulation of one osmolyte results in reciprocal depletion of others. Diabetic neuropathy may be an example of maladaptive osmoregulation, nerve damage and instability being aggravated by taurine depletion.
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Although the cause of diabetic neuropathy remains unknown, evidence implicates involvement of the polyol pathway, by which glucose is metabolized to sorbitol and fructose by aldose reductase (AR2) and sorbitol dehydrogenase, respectively [1, 2] . The compatible osmolyte hypothesis predicts that organic osmolytes including taurine, myo-inositol (MI) and sorbitol respond co-ordinately in response to changes in external osmolality to maintain the intracellular milieu [3] . Excess accumulation of intracellular sorbitol by activation of the polyol pathway in diabetes mellitus may therefore precipitate reciprocal depletion of other intracellular osmolytes. Depletion of nerve MI may result in disturbances of the calciumdependent phosphoinositide metabolism and secondary defects of nerve Na/K-ATPase activity, resulting in the acutely reversible slowing of nerve conduction [2, 4] .
Taurine (2-aminoethanesulphonic acid) is an ubiquitous beta amino acid which has been shown to function as an osmolyte in the eye, brain and kidney [5] [6] [7] [8] [9] . Within the kidney, taurine has been identified as the major amino acid in the renal inner medulla of rats where it functions as an osmolyte with concentrations increasing in response to dehydration [8, 9] . Taurine is widely distributed in man, being found in the highest concentrations in tissues which are prone to diabetic complications [10] . It functions as an anti-oxidant [5, 11] and inhibitory neurotransmitter [12, 13] , and it promotes neuronal repair and regeneration [13] . It has analgesic properties as it acts as a modulator of central pain perception [14, 15] . It regulates free cytosolic calcium and taurine deficiency results in increased free calcium and cell hyperexcitability [16, 17] . The spontaneously diabetic BB-rat and the streptozotocin diabetic (STZ-D) rat demonstrate structural and functional neural lesions similar to those seen in diabetic patients [18] . Specifically, neuronal hyperexcitability [19] , reduced nerve conduction velocity (NCV) and impaired nerve regene-ration occur early in the diabetic state [18, 20] . We propose that taurine is essential for the maintenance of neuronal integrity, and hypothesize that taurine deficiency may result in nerve hyperexcitability responsible for early painful diabetic neuropathy.
The interrelationships of the osmolytes taurine, MI and sorbitol were studied in peripheral nerve of the STZ-D rat after diabetes-induced nerve sorbitol accumulation or dietary supplementation of taurine or MI, or both. The functional effects of osmolyte disturbances were assessed by measuring sciatic nerve NCV.
Materials and methods

Research design
Cesarean-delivered, barrier-sustained, and overnight-fasted male albino Wistar rats weighing 200-300 g, were used. They were rendered diabetic by an i. p. injection of streptozotocin (60 mg/kg) (Upjohn, Kalamazoo, Mich., USA) in 0.2 ml of 10 mmol/1 citrate buffer pH 5.5 [21] . Plasma glucose was determined from tail vein blood with a Beckman glucose analyzer II (Beckman Instruments, Fullerton, Calif., USA). For inclusion in the study, diabetic rats had to have a non-fasting plasma glucose concentration of greater than 16.7 mmol/1 in heparinized tail vein blood, 48 h after STZ injection and at the end of the study. All animals were maintained in individual air-filtered metabolic cages and given access to water and suitably modified rat chow ad libitum. All synthetic diets were obtained from ICN Biomedicals (Cleveland, Ohio, USA).
Rats were acclimatized to their new environment for one week prior to the start of the study. All end-point measurements were made by investigators who were unaware of the identity of the experimental assignment. Two days after the induction of diabetes, animals were randomly assigned to the following experimental groups.
1. Non-diabetic control animals given standard synthetic rat chow (taurine undetectable, MI content 0.011% weight/weight (w/w)); 2. Non-diabetic animals given synthetic rat chow supplemented with 5 % w/w taurine; 3. Diabetic animals given standard synthetic rat chow; 4. Diabetic animals given synthetic rat chow supplemented with 5 % w/w taurine; 5. Diabetic animals given standard synthetic rat chow together with the ARI sorbinil suspended in distilled water (final concentration 4-5 mg/ml) as previously described [2, 21] and administered daily by gavage at a dose of 20 mg/kg; and 6. Diabetic animals given synthetic rat chow supplemented with 1% w/w MI.
The duration of the experiment was 21 days after which the NCV was measured, and the left and right sciatic nerves were rapidly surgically exposed from the vertebral exit to the common peroneal bi-609 furcation, excised, and cleaned of adherent muscle and loose epineural connective tissue [22] . Nerve was immediately frozen in liquid nL trogen for subsequent determination of nerve osmolyte levels [23, 24] . Percutaneously 3 ml of cardiac blood was withdrawn and centrifuged at 4 ~ for 15 min and 3300 rev/min to obtain plasma for determination of plasma osmolality.
Measurement of NCV
Animals were lightly anaesthetized with an injection of 30-40 mg pentobarbitol sodium/kg body weight i. p. and NCV was determined non-invasively in the left sciatic tibial conducting system [22] . The body temperature was monitored using a rectal probe and maintained at 37 ~ throughout the measurement using a warming pad. The left sciatic nerve was stimulated proximally at the sciatic notch and distally at the ankle via bipolar electrodes with supramaximal stimuli (8 V) from a stimulator at 20 Hz. The latencies of the compound muscle action potentials were recorded via bipolar electrodes from the first interosseous muscle of the hindpaw. The latencies were measured from the stimulus artifact to the onset of the negative M-wave deflection. The NCV was calculated by subtracting the distal latency from the proximal latency measured in milliseconds and the result was divided into the distance between the stimulating and recording electrodes measured in millimeters, giving a value for NCV in meters per second (m/s).
Measurement of sciatic nerve MI, sorbitol and fructose
Sciatic nerve MI, sorbitol and fructose were determined by gas chromatography of protein-free sciatic nerve homogenates (5% weight/volume trichloroacetic acid), and expressed as nmol/mg wet weight of tissue using a modification of a method that we have previously described [23, 24] . The determinations were performed on aldonitrile acetate derivatives of lyophilized aliquots of filtrates containing alpha-D-methyl mannopyranoside as an internal standard in a Varian 3700 gas-liquid chromatograph (Varian Sunnyvale, Calif., USA) with a sinNe flame ionization detector. Samples were injected using a Varian 8100 autosampler and the data analysed on a Varian Star Workstation integrator. The instrument was equipped with one 30 m, 0.25 mm inner diameter SP-2100 fused silica capillary column with a 0.25 btm film thickness. The column flow rate was 0.6 ml/min with a nitrogen carrier gas flow of 36.6 ml/min with a flame ionization detector maintained at 250 ~ Standard curves were generated daily.
Measurement of taurine
Sciatic nerve taurine concentrations were determined by high performance liquid chromatography (HPLC) using a modification of a method previously described [25] and expressed as nmol/mg wet weight. Approximately 20 mg of nerve was homogenized in 1 ml of 6 % trichloroacetic acid (TCA) and then centrifuged for 15 min at 4000 rev/min. To 0.5 ml of supernatant, 0.5 ml of TNO:freon [1:3] Table 1 . Comparison of body weight and plasma glucose in non-diabetic control, taurine supplemented non-diabetic control, diabetic, taurine supplemented diabetic, aldose reductase inhibitor (ARI) treated diabetic and myo-inositol (MI) supplemented diabetic rats at baseline and at the conclusion on day 21
Control
Control + taurine Diabetic Diabetic + taurine Diabetic + ARI Diabetic + MI (n = 10) (n = 8) (n = 12) (n = 8) (n = 9) (n = 10) 
Statistical analysis
Data are expressed as mean + SEM. Differences among experimental groups were detected by ANOVA, and the significance of differences between these groups assessed by the Student-NewmanKeuls multiple range test. As the variances for most of the variables were found to differ significantly, a logarithmic transformation was performed which corrected the unequal variances. All analyses were then performed on the transformed data. Significance was defined at the 0.05 level.
(trioctylamine: 1,1,2-trichlorotrifluoroethane) was added and vortexed for 1 min. After confirming that betaine was not present in the nerve samples and did not appear after exposure to the experimental conditions, betaine (500 nmol in 10 gl) was used as internal standard. The sample was again centrifuged for 15 min at 4000 rev/min. The aqueous supernatant was then passed through a 0.45 gm filter to remove any significant particulate matter. All HPLC data were collected on a Waters system (Waters Chromatography Division, Millipore Corp., Milford, Mass., USA) equipped with a model 600 pump and a manual injector, a model 410 differential refractometer and a column heater module. Data was recorded and processed on a Waters 746 data module. A Sugar Pak 1 (Waters) calcium cation exchange column (300 x 6.5 mm) was used as the stationary phase. The column was pre-heated and maintained at 87 ~ The mobile phase consisting of HPLC grade water with 50 mg/1 calcium disodium EDTA was degassed under vacuum while stirring. A flow rate of 0.6 ml/min was used. Volumes of 20 gl were injected for assay. Calibration curves were constructed for taurine, betaine and sorbitol, 
Results
Effects of STZ-D and dietary taurine and MI supplementation
The effects of diabetes and taurine feeding on NCV
The STZ-D animals showed a 23 % (p < 0.01) decrease in NCV after 21 days of diabetes compared to the nondiabetic control animals ( Table 2 ). Dietary taurine supplementation for 21 days to the non-diabetic animals reduced NCV by 12 % compared to the non-diabetic control animals, but after logarithmic transformation this failed to achieve statistical significance, but was not however significantly different from diabetic control animals. Restoring nerve taurine levels in the STZ-D animals by dietary taurine supplementation did not effect NCV which did not differ significantly from the untreated diabetic control animals.
The effect of ARI and MI supplementation on NCV
Nerve conduction velocity was increased by 17.1% (p < 0.05) in the STZ-D animals given an ARI but still remained below the non-diabetic control animals ( Fig.2 . The effect of 5 % dietary taurine supplementation on nerve osmolyte levels in non-diabetic control animals (control), nondiabetic animals given taurine diet (control-Tan), diabetic animals (diabetic) and diabetic animals given taurine diet (diabetic-Tan). After 21 days of experimental conditions the animals were killed and the sciatic nerves were removed for measurement of nerve taurine 9 (by HPLC) and myo-inositot n, glucose 9 sorbitol 9 and fructose [] by gas chromatography (see Materials and methods 
Change in plasma osmolality
The plasma osmolality of the different experimental groups is shown in Figure 1 . The plasma osmolality of the non-diabetic control animals was 282 + 4 mosmol/kg which was not significantly different from the nondiabetic animals given the taurine supplemented diet (283 + 2 mosmol/kg). All STZ-D animals showed an in-crease in plasma osmolality after 21 days of diabetes, the increase ranging from 7 % (302 _+ 4 mosmol/kg, p < 0.01) in the STZ-D group given dietary MI supplementation to 10% (309 + 4 mosmol/kg, p < 0.01) in the STZ-D animals given an ARI. No significant differences were detected however between the STZ-D groups.
Effect of diabetes on nerve glucose
Neither taurine nor MI feeding nor the administration of sorbinil was found to influence nerve glucose levels as all groups of STZ-D animals achieved similar nerve glucose levels which were 2.6-2.9-fold (p < 0.01) above basal nondiabetic animals. No significant differences in mean nerve glucose levels were found between the STZ-D groups (Figs. 2 and 3) .
Effect of diabetes and taurine supplementation on nerve osmolytes
Taurine was clearly identified by HPLC as being present in larger quantities than MI in all nerve samples assayed. STZ-D animals showed a 31% decrease in taurine (p < 0.01) and 37 % decrease in MI levels (p < 0.05) after 21 days of diabetes, which coincided with accumulation of sorbitol (Fig. 2) . Taurine supplementation of the diet increased nerve taurine levels by 27 % in non-diabetic animals and by 78 % in STZ-D animals, the diabetic animals now having taurine levels 22 % (p < 0.05) greater than nondiabetic control animals. Taurine feeding of non-diabetic animals resulted in a 25 % decrease in nerve MI levels, although after logarithmic transformation, this decrease failed to achieve statistical significance. Basal nerve sorbitol levels were similar in both the non-diabetic control and taurine-fed control animals and were increased 7.1-fold in STZ-D animals and 5.7-fold in taurine fed STZ-D animals. Fructose levels were found to increase by 5.1-fold in the untreated STZ-D animals and by 3.5-fold in the taurine-fed STZ-D animals compared to the non-diabetic control group. Sorbitol decreased by 8 % and20 % and fructose decreased by 8 % and 32 % in the taurine-fed non-diabetic and STZ-D animals, respectively. These decreases however did not reach statistical significance.
Effect of sorbinil and Ml feeding on nerve osmolytes
The administration of sorbinil to STZ-D animals resulted in a 54% (p < 0.01) and 58 % (p < 0.05) decrease in nerve sorbitol and fructose, respectively, although neither level was restored to normal non-diabetic values (Fig. 3) . Sorbinil increased nerve taurine levels 22 % (p < 0.05) over untreated STZ-D animals, levels being restored to 84 % of the non-diabetic levels. MI levels were found to be restored to 87 % of non-diabetic levels, an increase of 38 % (p < 0.05) in the sorbinil treated vs the STZ-D animals. MI feeding of the STZ-D animals restored nerve MI levels to non-diabetic levels and resulted in a 1.7-fold (p < 0.01) increase in nerve MI over the standard STZ-D animals. MI feeding of STZ-D animals was associated with a 9 % decrease in nerve taurine levels, a 14 % decrease in nerve sorbitol levels, and 25 % decrease in nerve fructose levels, compared to untreated STZ-D animals, which did not reach significance.
Discussion
These results show that taurine depletion occurs in the peripheral nerve in experimental diabetes as sorbitol accumulates. Furthermore, prevention of sorbitol accumulation by the ARI sorbinil restores nerve taurine levels towards normal. MI has also previously been shown to be depleted in a similar fashion in experimental and human diabetes [23, 26] and this was confirmed in the present study. Taurine and MI appear to have reciprocal relationships to each other in the nerve: taurine feeding in diabetes further compounds the MI depletion. Taurine depletion in the nerve does not appear to be responsible for the decrease in NCV seen in acute experimental diabetes since restoration of taurine levels to non-diabetic levels by dietary supplementation had no effect on NCV. This contrasted with MI feeding which significantly improved NCV. Furthermore, taurine dietary supplementation in the non-diabetic state tended to deplete nerve MI levels which was accompanied by a deterioration in NCV. MI supplementation led to a slight though not significant reduction in nerve taurine levels. These data are consistent with the hypothesis that sorbitol, taurine and MI act as interdependent osmolytes within the peripheral nerve. The functional consequences of taurine depletion remain to be established. It is now thought that the main function of aldose reductase (AR2) is osmoregulation, a process by which a cell maintains its volume and internal milieu in the face of changes in external osmolarity [27] . The peripheral nerve has been shown to contain abundant AR2, both in the Schwann cell and in the endoneurial vasculature [28] , although its localization in the latter has been disputed [29] . Sorbitol, which is generated by AR2 in the presence of excessive glucose, is poorly diffusible across the cell membrane and has been shown to accumulate in diabetic nerve [23, 30] . In nerve, sorbitol is further metabolized to fructose, which although like glucose is present in higher quantities than sorbitol, may not contribute as significantly to the osmolyte fluxes due to its higher membrane permeability. Elucidation of its contribution to nerve osmoregulation awaits the development of selective sorbitol dehydrogenase inhibitors. Accumulation of sorbitol may therefore result in an osmotically-induced reciprocal depletion of taurine and MI. AR2 activity is induced by hyperosmotic stimuli via an induction of the AR2 gene [31] . This is important in the kidney, where cells adapted to hyperosmolality demonstrate high basallevels of AR2 protein and respond to changes in external osmolality by altering their intracellular concentration of sorbitol [32] . [37] . In RPE cells, increases in osmolality of the magnitude observed in this study in the diabetic animals are not sufficient to induce the AR2 gene [37] . This may imply that individual variation in basal activity or expression of AR2 will determine sorbitol accumulation and secondary compensatory depletion of taurine and MI.
Sorbitol and MI are polyols which are members of one class of non-perturbing organic osmolytes, levels of which are adjusted in response to external osmolality, thereby keeping perturbing salts, such as NaC1 and KC1, levels constant which in excess would inhibit many metabolic processes [3] . Other classes of organic osmolytes include free amino acids, for example taurine and the methylamines, betaine and glycerophosphorylcholine (GPC) [3, 31, 32, 38] . Levels of these osmolytes are interdependent and reciprocally deplete or accumulate in response to osmotic challenge [3] . We were unable to detect either betaine or GPC in the peripheral nerve, thus implying their greater importance in the kidney. High intracellular concentrations of taurine have been found in tissues which have a limited capacity for taurine biosynthesis [39] , which implies that taurine is taken up against its concentration gradient. Like MI, taurine is accumulated by a sodiumdependent co-transporter [40] . This co-transporter has a higher affinity for beta amino acids than alpha amino acids [40] and requires chloride [40] [41] [42] .
Taurine is found in very high concentrations in the brain where it is localized in both glial and neuronal fractions [43] . A previous report has documented its presence within peripheral nerve [44] . In the nervous system it has been suggested that taurine acts as a neuromodulator or inhibitory neurotransmitter [12, 13] and can hyperpolarize hippocampal pyramidal cells [45, 46] . It is thought that taurine induces membrane hyperpolarization by increasing inward chloride ionic conductance [45, 47] and it has been implicated as a modulator of neuronal hyperexcitability, via both its hyperpolarizing effect, and by inhibition of calcium/calmodulin-dependent protein kinases [48] . This calcium-dependent protein kinase is widely distributed in neuronal tissue and is believed to contribute to the regulation of neurotransmitter release and ion conductance [49, 50] . Increased oxidative damage has been proposed in the pathogenesis of diabetic complications [51] , a process which may be exacerbated by taurine depletion as it is thought to act as an anti-oxidant [5, 11] . High levels of taurine are found in fetal nerve tissue and progressively decline with increasing age [52] implicating its importance in neuronal growth and development. Taurine has neurotrophic actions [13] and may potentially promote neuronal regeneration, which is depressed in diabetes [4, 18, 53] . Accelerated diabetes-induced nerve taurine depletion may thus contribute to the impaired regenerative capacity of diabetic peripheral nerve.
Many of the effects of taurine may result from the regulation of intracellular calcium levels [16] . Deficiency of taurine may result in increased free calcium which may further aggravate neuronal hyperexcitability [16, 17] . Potentially this calcium-induced hyperexcitability may occur acutely at either the neuronal cell body, precipitated by membrane instability [19] or impaired neurotransmitter release at sensory nerve terminals. The pain-modulating role of taurine in both acute and chronic painful neuropathy could also involve interaction with the endogenous opiate system as rats made tolerant to morphine exhibit altered distribution of taurine in the spinal cord [14] . Administration of substance P to the dorsal spinal cord of rats increases the extracellular fluid taurine concentration, which serves to block some of the nociceptive stimuli induced by its administration [12] .
Compensatory nerve osmolyte depletion in response to overproduction of sorbitol may be an example of osmoregulation which has gone awry. Depletion of taurine and MI may maintain intracellular osmotic balance at the expense of deteriorations of both nerve function and structure. Although dietary MI supplementation corrected nerve MI depletion and improved NCV, an effect which was independent of nerve glucose, sorbitol and fructose, this occurred at the expense of further taurine depletion. Conversely, taurine feeding of the non-diabetic animal tended to deplete MI and slow NCV, although a direct effect of taurine accumulation in the nerve cannot be excluded. In human and animal studies, ARI treatment, which prevents sorbitol synthesis and accumulation and secondary MI depletion, results in improvement of NCV and axonal transport [4] . The postulated mechanisms by which MI depletion results in impaired nerve function involves decreased sodium/potassium-ATPase activity which is important in maintaining the sodium gradient that drives both MI, and perhaps, taurine uptake in nerve. Defects in sodium/potassium-ATPase activity in the nerve result in axonal sodium accumulation, reduced resting membrane potential and subsequent impaired nerve function [2, 4, 19] . The relationships of taurine, MI and sorbitol may be critical in determining sodium/potassium-ATPase activity, intracellular Ca + § and neuronal Na § accumulation of the latter two precipitating neuronal hyperexcitability and reduced NCV, respectively. Future studies will need to directly address the function of taurine within the nerve, specifically by assessing whether repletion of taurine can stimulate nerve rep,~ir and regeneration and/or reduce the early diabetes-induced nerve hyperexcitability.
